Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) said it has no exposure to Silicon Valley Bank (SVB).
The collapse of the US lender has affected a number of technology and life sciences companies listed here in the UK.
However, the Main Market-listed biotech confirmed on Monday: “Roquefort Therapeutics confirms that it does not have any exposure to SVB, either in relation to cash deposits, investments or debt facilities.”